Vestibular system in infants after systemic therapy with amikacin

Olaf Zagólski1

  • 1Diagnostic and Therapeutic Medical Centre Medicina, Kraków, Poland. olafzag@poczta.onet.pl

Insights

Aminoglycoside antibiotics can damage infant vestibular function. Caloric tests and vestibular evoked myogenic potentials (VEMPs) revealed more frequent vestibular than cochlear damage, highlighting the need for routine vestibular screening in infants post-treatment.

Area of Science:

  • Pediatric Otolaryngology
  • Neuroscience
  • Pharmacology

Background:

  • Aminoglycosides are crucial for treating infant infections but carry ototoxic risks.
  • Routine infant inner ear examinations often omit vestibular function tests.
  • Vestibular damage can have significant long-term impacts on development.

Purpose of the Study:

  • To evaluate vestibular function in infants before and after aminoglycoside therapy.
  • To compare the sensitivity of caloric tests and VEMPs in detecting aminoglycoside-induced ototoxicity.
  • To determine if vestibular or cochlear function is more affected by amikacin treatment.

Main Methods:

  • A randomized clinical study involving 68 infants (2.5-3.5 months old) at a tertiary referral center.
  • Vestibular evoked myogenic potentials (VEMPs) and caloric stimulation were performed on 28 infants treated with amikacin and 40 healthy controls.
  • Tests were conducted upon hospital admission and discharge to assess changes in vestibular function.

Main Results:

  • No caloric stimulation response in 6 infants and no VEMPs in 4 infants upon discharge.
  • Hearing thresholds remained normal in all infants throughout the study.
  • Caloric testing proved more sensitive than VEMPs in detecting amikacin's ototoxic effects on vestibular receptors.

Conclusions:

  • Amikacin treatment can damage both semicircular canal and otolith organ receptors in infants.
  • The semicircular canal receptors appear to be more frequently impaired.
  • Routine vestibular testing is recommended for infants following aminoglycoside therapy to monitor for ototoxicity.
Abstract

Related Concept Videos

The Vestibular System01:29

The Vestibular System

The vestibular system is a set of inner ear structures that provide a sense of balance and spatial orientation. This system is comprised of structures within the labyrinth of the inner ear, including the cochlea and two otolith organs—the utricle and saccule. The labyrinth also contains three semicircular canals—superior, posterior, and horizontal—that are oriented on different planes.
Equilibrium and Balance01:15

Equilibrium and Balance

The inner ear assumes dual functionalities of auditory perception and equilibrium maintenance. The vestibule is the organ responsible for balance. This organ contains mechanoreceptors, specifically hair cells, endowed with stereocilia, which aid in deciphering information regarding the position and motion of our heads. Two intrinsic components, the utricle and saccule, help perceive head position, while the semicircular canals track head movement. Neurological messages initiated in the...
Estimation of k and VD of Aminoglycosides01:20

Estimation of k and VD of Aminoglycosides

Aminoglycosides are a class of antibiotics used to treat various bacterial infections. Clinicians must determine the elimination rate constant (k) and volume of distribution (VD) to optimize therapeutic efficacy and minimize toxicity. The k value represents the rate at which the drug is removed from the body, and the VD reflects the degree to which the drug distributes into body tissues. Accurately estimating these parameters allows healthcare professionals to tailor drug dosing to individual...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...